Key Points
New Delhi:Finance Minister Nirmala Sitharaman, presenting the Union Budget 2024-25 Tuesday, announced a full exemption from customs duties for three more cancer drugs a move that will likely benefit thousands of cancer patients...
Trastuzumab deruxtecan, sold under the brand name Enhertu, is used in treating specific breast, stomach and lung cancers, and osimertinib, sold under the brand name Tagrisso, is used in treating advanced cases of certain lung cancers.On the other hand, Durvalumab, sold under the brand name Imfinzi, works for several types of malignancies involving the lungs, endometrium, and biliary tract...
While the allocation to health, family welfare, and health research shows a modest increase compared to the previous years revised estimate, it may fall short of the proposed health agenda of strengthening the surveillance of zoonotic infections, controlling antimicrobial resistance, upscaling primary care services and strengthening district hospitals, said Dr K..
The proposal to include elderly persons in the Ayushman Bharat- Pradhan Mantri Jan Aarogya Yojana (a health insurance scheme for the poor, providing insurance coverage of up to Rs 5 lakh) led to expectations that the scheme would see a greater increase than the seven percent provided by the budget, Reddy said.. While the proposal to exempt three imported cancer drugs from customs duty is welcome, the government should ensure price control on drugs through pooled public procurement, said Reddy...
These include increasing the GDP spending on healthcare to2.5 percent, prioritising healthcare as a national issue, promoting medical value travel in India, among others, Raghuvanshi said.. (Edited by Madhurita Goswami)..
